AN2 Therapeutics, Inc. (NASDAQ:ANTX) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
AN2 Therapeutics, Inc.'s stock currently trades at $1.13 with a market capitalization of $32.6M. The Healthcare company's stock moved following the disclosure.